학술논문
Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations: A phase 1b clinical trial and biomarker analysis
Document Type
Article
Author
Source
In Lung Cancer February 2024 188
Subject
Language
ISSN
0169-5002